Publication | Closed Access

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

UrologyRenal FunctionMedicineRadionuclide TherapyLong-term EvaluationRadiopharmaceutical TherapyToxicologyPharmacotherapyPharmacologyNuclear MedicineRisk FactorsNephrologyRenal Toxicity